Echo Therapeutics, Inc. Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis with Unobservable Inputs
Echo Therapeutics, Inc. had Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis with Unobservable Inputs of $113.00 thousand as of 2014-09-30, per its 10-Q filed 2015-04-20.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs · last filed 2015-04-20
- 2014-09-30: Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis with Unobservable Inputs $113.00K.
- 2014-06-30: Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis with Unobservable Inputs $586.00K.
- 2014-03-31: Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis with Unobservable Inputs $979.00K.
- 2013-12-31: Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis with Unobservable Inputs $1.12M.
| Period end | Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis with Unobservable Inputs |
|---|---|
| 2014-09-30 | $113.00K 10-Q · filed 2015-04-20 |
| 2014-06-30 | $586.00K 10-Q · filed 2014-08-14 |
| 2014-03-31 | $979.00K 10-Q · filed 2014-05-12 |
| 2013-12-31 | $1.12M 10-Q · filed 2015-04-20 |
| 2013-09-30 | $979.00K 10-Q · filed 2013-11-07 |
| 2013-06-30 | $909.00K 10-Q · filed 2013-08-09 |
| 2012-12-31 | $5.58M 10-K · filed 2014-03-28 |